• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

类风湿关节炎对骨质流失的影响:与骨质疏松症和骨质减少的关联。

The Impact of Rheumatoid Arthritis on Bone Loss: Links to Osteoporosis and Osteopenia.

作者信息

Kareem Roaa, Botleroo Rinky A, Bhandari Renu, Ogeyingbo Opemipo D, Ahmed Rowan, Gyawali Mallika, Venkatesan Nanditha, Elshaikh Abeer O

机构信息

Internal Medicine, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.

Medicine, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.

出版信息

Cureus. 2021 Aug 28;13(8):e17519. doi: 10.7759/cureus.17519. eCollection 2021 Aug.

DOI:10.7759/cureus.17519
PMID:34603889
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8476196/
Abstract

Rheumatoid arthritis (RA) is an autoimmune chronic connective tissue disease that produces persistent systemic inflammation, with joint inflammation leading to function loss and joint destruction. Low bone mass causes skeletal bone loss, commonly referred to as osteopenia or osteoporosis.  We conducted this literature review to examine the relationship between RA and osteoporosis and the variables contributing to this connection. We used articles from the US National Library of Medicine (PubMed), Google Scholar, Science Direct to access the required information. Eventually, our results concluded that RA could result in local periarticular and generalized bone loss. Many risk factors contribute to this association, such as chronic joints inflammation, glucocorticoid use, genetics, and estrogen hormone effects. Still, it is not clear yet whether this is due to a consequence of treatment, immobility, or the activity of the disease. There are many recommendations by the American College of Rheumatology for RA patients during the disease course to reduce the risk of osteoporosis development, which include early starts of disease-modifying anti-inflammatory drugs (DMARDs), doing a dual-energy x-ray (DXA) or quantitative ultrasound (QUS) for identifying a patient at risk of osteoporosis, taking vitamin D, calcium, and bisphosphonates. Further prospective studies and clinical trials are essential to provide a solid evidence-based recommendation that will help to prevent bone loss in RA patients.

摘要

类风湿关节炎(RA)是一种自身免疫性慢性结缔组织疾病,会引发持续性全身炎症,关节炎症会导致功能丧失和关节破坏。低骨量会导致骨骼骨质流失,通常称为骨质减少或骨质疏松症。我们进行了这项文献综述,以研究RA与骨质疏松症之间的关系以及促成这种关联的变量。我们使用了来自美国国立医学图书馆(PubMed)、谷歌学术、科学Direct的文章来获取所需信息。最终,我们的结果得出结论,RA可能导致局部关节周围和全身性骨质流失。许多风险因素促成了这种关联,如慢性关节炎症、糖皮质激素的使用、遗传因素以及雌激素的影响。不过,目前尚不清楚这是由于治疗、活动减少还是疾病活动所致。美国风湿病学会针对RA患者在病程中提出了许多建议,以降低骨质疏松症发生的风险,这些建议包括尽早开始使用改善病情的抗风湿药物(DMARDs)、进行双能X线吸收法(DXA)或定量超声(QUS)检查以识别有骨质疏松症风险的患者、补充维生素D、钙和双膦酸盐。进一步的前瞻性研究和临床试验对于提供坚实的循证建议至关重要,这将有助于预防RA患者的骨质流失。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6936/8476196/a159ed3b7aef/cureus-0013-00000017519-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6936/8476196/c45bdd762157/cureus-0013-00000017519-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6936/8476196/a159ed3b7aef/cureus-0013-00000017519-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6936/8476196/c45bdd762157/cureus-0013-00000017519-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6936/8476196/a159ed3b7aef/cureus-0013-00000017519-i02.jpg

相似文献

1
The Impact of Rheumatoid Arthritis on Bone Loss: Links to Osteoporosis and Osteopenia.类风湿关节炎对骨质流失的影响:与骨质疏松症和骨质减少的关联。
Cureus. 2021 Aug 28;13(8):e17519. doi: 10.7759/cureus.17519. eCollection 2021 Aug.
2
Hand bone mass in rheumatoid arthritis: A review of the literature.类风湿关节炎中的手部骨量:文献综述
World J Orthop. 2015 Jan 18;6(1):106-16. doi: 10.5312/wjo.v6.i1.106.
3
Detailed analyses of periarticular osteoporosis in rheumatoid arthritis.类风湿关节炎关节周围骨质疏松的详细分析
Osteoporos Int. 2000;11(5):400-7. doi: 10.1007/s001980070106.
4
Positive Effects of Biologics on Osteoporosis in Rheumatoid Arthritis.生物制剂对类风湿关节炎骨质疏松症的积极作用。
J Rheum Dis. 2023 Jan 1;30(1):3-17. doi: 10.4078/jrd.22.0046.
5
Management of osteoporosis in rheumatoid arthritis patients.类风湿关节炎患者骨质疏松症的管理
Expert Opin Pharmacother. 2015 Mar;16(4):559-71. doi: 10.1517/14656566.2015.997709. Epub 2015 Jan 27.
6
Assessing periarticular bone mineral density in patients with early psoriatic arthritis or rheumatoid arthritis.评估早期银屑病关节炎或类风湿关节炎患者的关节周围骨密度。
Ann Rheum Dis. 2002 Nov;61(11):1007-11. doi: 10.1136/ard.61.11.1007.
7
[Osteoporosis in rheumatoid arthritis].[类风湿关节炎中的骨质疏松症]
Nihon Rinsho. 1998 Jun;56(6):1598-603.
8
Skeletal complications of rheumatoid arthritis.类风湿关节炎的骨骼并发症。
Osteoporos Int. 2017 Oct;28(10):2801-2812. doi: 10.1007/s00198-017-4170-5. Epub 2017 Aug 4.
9
[Osteoporosis in rheumatoid arthritis--significance of alfacalcidol in prevention and therapy].[类风湿关节炎中的骨质疏松——阿法骨化醇在预防和治疗中的意义]
Z Rheumatol. 2000;59 Suppl 1:10-20. doi: 10.1007/s003930070032.
10
The Utility of Radiographic Focal Erosions of Hands or Feet in Predicting DXA-defined Osteoporosis of the Hip in Patients with Rheumatoid Arthritis.手部或足部X线片上的局限性侵蚀在预测类风湿关节炎患者双能X线吸收法(DXA)定义的髋部骨质疏松中的应用
Curr Rheumatol Rev. 2020;16(1):74-78. doi: 10.2174/1573397115666190716120127.

引用本文的文献

1
Cytokine Signatures as Biomarkers of Clinical Remission in Rheumatoid Arthritis.细胞因子特征作为类风湿关节炎临床缓解的生物标志物
J Inflamm Res. 2025 Jun 25;18:8345-8356. doi: 10.2147/JIR.S527601. eCollection 2025.
2
A novel nomogram for predicting osteoporosis with low back pain among the patients in Wenshan Zhuang and Miao Autonomous Prefecture of China.中国文山壮族苗族自治州患者中用于预测伴有腰痛的骨质疏松症的新型列线图。
Front Endocrinol (Lausanne). 2025 Jun 5;16:1535163. doi: 10.3389/fendo.2025.1535163. eCollection 2025.
3
Using Radiofrequency Echographic Multi-spectrometry in the Follow-Up of Patients With Axial Spondyloarthritis and Psoriatic Arthritis.

本文引用的文献

1
Rheumatoid arthritis and osteoporosis: shared genetic effect, pleiotropy and causality.类风湿关节炎和骨质疏松症:共同的遗传效应、多效性和因果关系。
Hum Mol Genet. 2021 Oct 13;30(21):1932-1940. doi: 10.1093/hmg/ddab158.
2
Associations of Changes in Serum Inflammatory Factors, MMP-3, 25(OH)D and Intestinal Flora with Osteoporosis and Disease Activity in Rheumatoid Arthritis Patients.血清炎症因子、MMP-3、25(OH)D 和肠道菌群变化与类风湿关节炎患者骨质疏松及疾病活动的相关性。
Clin Lab. 2020 Dec 1;66(12). doi: 10.7754/Clin.Lab.2020.200242.
3
Bone Loss, Osteoporosis, and Fractures in Patients with Rheumatoid Arthritis: A Review.
在轴性脊柱关节炎和银屑病关节炎患者随访中使用射频超声多光谱分析技术
Cureus. 2025 May 18;17(5):e84370. doi: 10.7759/cureus.84370. eCollection 2025 May.
4
Tocilizumab Monotherapy or Combined With Methotrexate for Rheumatoid Arthritis: A Randomized Clinical Trial.托珠单抗单药治疗或联合甲氨蝶呤治疗类风湿关节炎:一项随机临床试验。
JAMA Netw Open. 2025 May 1;8(5):e2511095. doi: 10.1001/jamanetworkopen.2025.11095.
5
Identification of immune characteristic biomarkers and therapeutic targets in cuproptosis for rheumatoid arthritis by integrated bioinformatics analysis and single-cell RNA sequencing analysis.通过综合生物信息学分析和单细胞RNA测序分析鉴定类风湿关节炎铜死亡中的免疫特征生物标志物和治疗靶点
Front Med (Lausanne). 2025 Mar 17;12:1520400. doi: 10.3389/fmed.2025.1520400. eCollection 2025.
6
Potential association of rheumatic diseases with bone mineral density and fractures: a bi-directional mendelian randomization study.风湿性疾病与骨密度和骨折的潜在关联:一项双向孟德尔随机化研究。
BMC Musculoskelet Disord. 2024 Jul 5;25(1):521. doi: 10.1186/s12891-024-07496-w.
7
Challenges and Pitfalls of Research Designs Involving Magnesium-Based Biomaterials: An Overview.涉及镁基生物材料的研究设计的挑战和陷阱:概述。
Int J Mol Sci. 2024 Jun 5;25(11):6242. doi: 10.3390/ijms25116242.
8
Correlation between Trabecular Bone Score and Homocysteine Level in Rheumatoid Arthritis Patients on Anti-TNF Inhibitors.类风湿关节炎患者使用抗TNF抑制剂时小梁骨评分与同型半胱氨酸水平的相关性
Life (Basel). 2024 Apr 1;14(4):463. doi: 10.3390/life14040463.
9
An Overview on the Big Players in Bone Tissue Engineering: Biomaterials, Scaffolds and Cells.骨组织工程中的主要参与者概述:生物材料、支架和细胞。
Int J Mol Sci. 2024 Mar 29;25(7):3836. doi: 10.3390/ijms25073836.
10
Osteopontin, osteoprotegerin and musculoskeletal ultrasound findings in first-degree relatives of rheumatoid arthritis: potential markers of preclinical disease.骨桥蛋白、护骨素和肌肉骨骼超声在类风湿关节炎一级亲属中的发现:临床前疾病的潜在标志物。
BMC Musculoskelet Disord. 2024 Mar 5;25(1):195. doi: 10.1186/s12891-024-07291-7.
类风湿关节炎患者的骨质流失、骨质疏松症和骨折:综述
J Clin Med. 2020 Oct 20;9(10):3361. doi: 10.3390/jcm9103361.
4
The impact of long-term biologics/target therapy on bone mineral density in rheumatoid arthritis: a propensity score-matched analysis.长期生物制剂/靶向治疗对类风湿关节炎患者骨密度的影响:倾向评分匹配分析。
Rheumatology (Oxford). 2020 Sep 1;59(9):2471-2480. doi: 10.1093/rheumatology/kez655.
5
Predictors of denosumab efficacy in treating osteoporosis in patients with rheumatoid arthritis: a Japanese multicenter study.地诺单抗治疗类风湿关节炎患者骨质疏松症疗效的预测因素:一项日本多中心研究。
Nagoya J Med Sci. 2019 Nov;81(4):571-585. doi: 10.18999/nagjms.81.4.571.
6
Male patients with rheumatoid arthritis have an increased risk of osteoporosis: Frequency and risk factors.类风湿关节炎男性患者骨质疏松风险增加:发生率及危险因素
Medicine (Baltimore). 2018 Jun;97(24):e11122. doi: 10.1097/MD.0000000000011122.
7
Glucocorticoid-induced osteoporosis: an update.糖皮质激素性骨质疏松症:更新。
Endocrine. 2018 Jul;61(1):7-16. doi: 10.1007/s12020-018-1588-2. Epub 2018 Apr 24.
8
Trends and Determinants of Osteoporosis Treatment and Screening in Patients With Rheumatoid Arthritis Compared to Osteoarthritis.类风湿关节炎患者骨质疏松治疗和筛查的趋势及决定因素与骨关节炎比较。
Arthritis Care Res (Hoboken). 2018 May;70(5):713-723. doi: 10.1002/acr.23331. Epub 2018 Mar 11.
9
Postmenopausal osteoporosis in rheumatoid arthritis: The estrogen deficiency-immune mechanisms link.绝经后类风湿关节炎相关骨质疏松症:雌激素缺乏-免疫机制的联系。
Bone. 2017 Oct;103:102-115. doi: 10.1016/j.bone.2017.06.020. Epub 2017 Jun 27.
10
Bone mineral density level by dual energy X-ray absorptiometry in rheumatoid arthritis.类风湿关节炎患者通过双能X线吸收法测定的骨矿物质密度水平
J Pak Med Assoc. 2017 Jan;67(1):15-19.